Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
epoprostenol (veletri) (1 trial)
leucovorin (1 trial)
levothyroxine (Synthroid) (1 trial)
Down Syndrome (Phase 3)
Familial Primary Pulmonary Hypertension (Phase 3)
Hypertension (Phase 3)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (3 total)